Julien Caldéraro

机构：Inserm, Université Paris-Est Créteil, Paris-Est Sup, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor, ERN GUARD-Heart, Hôpital Albert-Chenevier, Institut Mondor de Recherche Biomédicale · ORCID：0000-0002-5370-0807

发表论文 390 篇 · 总被引 22000 次 · h-index 64

代表论文

• Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 5)
• Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study (2026 · Liver Cancer · 被引 3)
• OS-054 A confidence-aware artificial intelligence pathology model for cholangiocarcinoma diagnosis (2026 · Journal of Hepatology · 被引 1)
• Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial) (2026 · Hepatology · 被引 1)
• Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study (2026 · Cancer Discovery · 被引 1)
• Stroma-driven intertumoral and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluation (2026 · Hepatology · 被引 1)